138 related articles for article (PubMed ID: 18229466)
1. Systemic sclerosis (scleroderma).
Roufosse FE; de Bellefon LM
Acta Clin Belg; 2007; 62(5):323-9. PubMed ID: 18229466
[TBL] [Abstract][Full Text] [Related]
2. Pathogenic autoantibodies in systemic sclerosis.
Gabrielli A; Svegliati S; Moroncini G; Avvedimento EV
Curr Opin Immunol; 2007 Dec; 19(6):640-5. PubMed ID: 18083509
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of Disease: the role of immune cells in the pathogenesis of systemic sclerosis.
Sakkas LI; Chikanza IC; Platsoucas CD
Nat Clin Pract Rheumatol; 2006 Dec; 2(12):679-85. PubMed ID: 17133253
[TBL] [Abstract][Full Text] [Related]
4. Stimulatory autoantibodies to the PDGF receptor: a link to fibrosis in scleroderma and a pathway for novel therapeutic targets.
Gabrielli A; Svegliati S; Moroncini G; Luchetti M; Tonnini C; Avvedimento EV
Autoimmun Rev; 2007 Dec; 7(2):121-6. PubMed ID: 18035321
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for severity and manifestations in systemic sclerosis and prediction of disease course.
Becker MO; Riemekasten G
Expert Rev Clin Immunol; 2016; 12(2):115-35. PubMed ID: 26558747
[TBL] [Abstract][Full Text] [Related]
6. New pathogenic and therapeutic concepts in systemic sclerosis.
Hügle T; Huigens CA; van Laar JM
Arzneimittelforschung; 2009; 59(12):615-24. PubMed ID: 20108646
[TBL] [Abstract][Full Text] [Related]
7. Scleroderma.
Gilliam AC
Curr Dir Autoimmun; 2008; 10():258-79. PubMed ID: 18460891
[TBL] [Abstract][Full Text] [Related]
8. Is there a role for B-cell depletion as therapy for scleroderma? A case report and review of the literature.
Daoussis D; Liossis SN; Tsamandas AC; Kalogeropoulou C; Kazantzi A; Korfiatis P; Yiannopoulos G; Andonopoulos AP
Semin Arthritis Rheum; 2010 Oct; 40(2):127-36. PubMed ID: 20004954
[TBL] [Abstract][Full Text] [Related]
9. Autoimmunity in scleroderma: the origin, pathogenetic role, and clinical significance of autoantibodies.
Harris ML; Rosen A
Curr Opin Rheumatol; 2003 Nov; 15(6):778-84. PubMed ID: 14569210
[TBL] [Abstract][Full Text] [Related]
10. Systemic sclerosis refractory disease: from the skin to the heart.
Almeida I; Faria R; Vita P; Vasconcelos C
Autoimmun Rev; 2011 Sep; 10(11):693-701. PubMed ID: 21575745
[TBL] [Abstract][Full Text] [Related]
11. Cellular and molecular mechanisms in the pathophysiology of systemic sclerosis.
Hua-Huy T; Dinh-Xuan AT
Pathol Biol (Paris); 2015 Apr; 63(2):61-8. PubMed ID: 25818311
[TBL] [Abstract][Full Text] [Related]
12. Altered B lymphocyte function induces systemic autoimmunity in systemic sclerosis.
Sato S; Fujimoto M; Hasegawa M; Takehara K; Tedder TF
Mol Immunol; 2004 Nov; 41(12):1123-33. PubMed ID: 15482848
[TBL] [Abstract][Full Text] [Related]
13. Induction of autoimmunity in a bleomycin-induced murine model of experimental systemic sclerosis: an important role for CD4+ T cells.
Ishikawa H; Takeda K; Okamoto A; Matsuo S; Isobe K
J Invest Dermatol; 2009 Jul; 129(7):1688-95. PubMed ID: 19158840
[TBL] [Abstract][Full Text] [Related]
14. Pathogenesis of systemic sclerosis: altered B cell function is the key linking systemic autoimmunity and tissue fibrosis.
Hasegawa M; Fujimoto M; Takehara K; Sato S
J Dermatol Sci; 2005 Jul; 39(1):1-7. PubMed ID: 15885984
[TBL] [Abstract][Full Text] [Related]
15. Pathogenesis and therapeutic approaches for improved topical treatment in localized scleroderma and systemic sclerosis.
Badea I; Taylor M; Rosenberg A; Foldvari M
Rheumatology (Oxford); 2009 Mar; 48(3):213-21. PubMed ID: 19022832
[TBL] [Abstract][Full Text] [Related]
16. [Pathophysiology of systemic sclerosis].
Allanore Y
Med Sci (Paris); 2016 Feb; 32(2):183-91. PubMed ID: 26936176
[TBL] [Abstract][Full Text] [Related]
17. B lymphocytes: shedding new light on the pathogenesis of systemic sclerosis.
Hasegawa M
J Dermatol; 2010 Jan; 37(1):3-10. PubMed ID: 20175836
[TBL] [Abstract][Full Text] [Related]
18. A modified model of graft-versus-host-induced systemic sclerosis (scleroderma) exhibits all major aspects of the human disease.
Ruzek MC; Jha S; Ledbetter S; Richards SM; Garman RD
Arthritis Rheum; 2004 Apr; 50(4):1319-31. PubMed ID: 15077316
[TBL] [Abstract][Full Text] [Related]
19. Endothelial/lymphocyte activation leads to prominent CD4+ T cell infiltration in the gastric mucosa of patients with systemic sclerosis.
Manetti M; Neumann E; Müller A; Schmeiser T; Saar P; Milia AF; Endlicher E; Roeb E; Messerini L; Matucci-Cerinic M; Ibba-Manneschi L; Müller-Ladner U
Arthritis Rheum; 2008 Sep; 58(9):2866-73. PubMed ID: 18759276
[TBL] [Abstract][Full Text] [Related]
20. Function blocking autoantibodies against matrix metalloproteinase-1 in patients with systemic sclerosis.
Sato S; Hayakawa I; Hasegawa M; Fujimoto M; Takehara K
J Invest Dermatol; 2003 Apr; 120(4):542-7. PubMed ID: 12648215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]